nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CES1—Phase I biotransformations, non P450—ESD—ocular cancer	0.199	0.241	CbGpPWpGaD
Capecitabine—TYMS—Trans-sulfuration and one carbon metabolism—PSPH—ocular cancer	0.024	0.0289	CbGpPWpGaD
Capecitabine—TYMS—G1/S-Specific Transcription—CDC25A—ocular cancer	0.0185	0.0223	CbGpPWpGaD
Capecitabine—TYMS—G1/S-Specific Transcription—TFDP1—ocular cancer	0.018	0.0218	CbGpPWpGaD
Capecitabine—Radiation recall reaction (dermatologic)—Dactinomycin—ocular cancer	0.0177	0.103	CcSEcCtD
Capecitabine—Recall phenomenon—Dactinomycin—ocular cancer	0.0167	0.0972	CcSEcCtD
Capecitabine—Neutropenic sepsis—Dactinomycin—ocular cancer	0.0167	0.0972	CcSEcCtD
Capecitabine—Venous thrombosis—Carboplatin—ocular cancer	0.0145	0.0841	CcSEcCtD
Capecitabine—CES1—E2F transcription factor network—CDKN2C—ocular cancer	0.0126	0.0152	CbGpPWpGaD
Capecitabine—TYMS—E2F mediated regulation of DNA replication—CDC25A—ocular cancer	0.0109	0.0131	CbGpPWpGaD
Capecitabine—TYMS—E2F mediated regulation of DNA replication—TFDP1—ocular cancer	0.0106	0.0128	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—E2F5—ocular cancer	0.0105	0.0126	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—E2F1—ocular cancer	0.0104	0.0126	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—E2F4—ocular cancer	0.0102	0.0124	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—MYBL2—ocular cancer	0.0102	0.0124	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—E2F2—ocular cancer	0.0101	0.0121	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—RBL1—ocular cancer	0.0101	0.0121	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—RBL2—ocular cancer	0.00923	0.0111	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN2C—ocular cancer	0.00872	0.0105	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—RBBP4—ocular cancer	0.00872	0.0105	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—E2F3—ocular cancer	0.00872	0.0105	CbGpPWpGaD
Capecitabine—TYMS—G1/S-Specific Transcription—E2F1—ocular cancer	0.00862	0.0104	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CDK4—ocular cancer	0.0085	0.0103	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CDC25A—ocular cancer	0.00829	0.01	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—TFDP1—ocular cancer	0.0081	0.00978	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—RB1—ocular cancer	0.00739	0.00892	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CCND3—ocular cancer	0.00735	0.00887	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—E2F5—ocular cancer	0.00726	0.00877	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—E2F4—ocular cancer	0.00711	0.00859	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—MYBL2—ocular cancer	0.00711	0.00859	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—E2F2—ocular cancer	0.00697	0.00842	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—RBL1—ocular cancer	0.00697	0.00842	CbGpPWpGaD
Capecitabine—Phlebitis—Carboplatin—ocular cancer	0.00658	0.0383	CcSEcCtD
Capecitabine—TYMS—E2F transcription factor network—RBL2—ocular cancer	0.0064	0.00773	CbGpPWpGaD
Capecitabine—Ascites—Dactinomycin—ocular cancer	0.00638	0.0371	CcSEcCtD
Capecitabine—TYMP—Bladder Cancer—MDM2—ocular cancer	0.0063	0.00761	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.00606	0.00732	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—E2F3—ocular cancer	0.00605	0.0073	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—RBBP4—ocular cancer	0.00605	0.0073	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDC25A—ocular cancer	0.00575	0.00695	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—TFDP1—ocular cancer	0.00562	0.00679	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CCND1—ocular cancer	0.00549	0.00662	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2C—ocular cancer	0.00534	0.00644	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CDKN1A—ocular cancer	0.00531	0.00641	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.00526	0.00635	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.00526	0.00635	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CCND3—ocular cancer	0.0051	0.00615	CbGpPWpGaD
Capecitabine—TYMS—E2F mediated regulation of DNA replication—E2F1—ocular cancer	0.00507	0.00612	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.005	0.00604	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.00489	0.0059	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—ocular cancer	0.00482	0.00583	CbGpPWpGaD
Capecitabine—Febrile neutropenia—Dactinomycin—ocular cancer	0.00482	0.028	CcSEcCtD
Capecitabine—CES1—E2F transcription factor network—HDAC1—ocular cancer	0.00471	0.00568	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—E2F5—ocular cancer	0.00444	0.00536	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.00443	0.00535	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—MYC—ocular cancer	0.0044	0.00531	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—E2F4—ocular cancer	0.00435	0.00525	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYBL2—ocular cancer	0.00435	0.00525	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—ocular cancer	0.0043	0.00519	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—RBL1—ocular cancer	0.00427	0.00515	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—E2F2—ocular cancer	0.00427	0.00515	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—CDC25A—ocular cancer	0.00417	0.00504	CbGpPWpGaD
Capecitabine—Hepatomegaly—Dactinomycin—ocular cancer	0.00409	0.0238	CcSEcCtD
Capecitabine—TYMS—G1/S Transition—TFDP1—ocular cancer	0.00408	0.00493	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—RBL2—ocular cancer	0.00392	0.00473	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—CRTC1—ocular cancer	0.00388	0.00469	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—E2F1—ocular cancer	0.00387	0.00468	CbGpPWpGaD
Capecitabine—Hepatotoxicity—Dactinomycin—ocular cancer	0.00375	0.0218	CcSEcCtD
Capecitabine—Coagulopathy—Dactinomycin—ocular cancer	0.00372	0.0217	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—E2F3—ocular cancer	0.0037	0.00447	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—RBBP4—ocular cancer	0.0037	0.00447	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—TP53—ocular cancer	0.00361	0.00436	CbGpPWpGaD
Capecitabine—TYMS—E2F mediated regulation of DNA replication—RB1—ocular cancer	0.00359	0.00434	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.00352	0.00425	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—ID2—ocular cancer	0.00346	0.00418	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—HRAS—ocular cancer	0.00346	0.00417	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.00344	0.00415	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—ocular cancer	0.00344	0.00415	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CDK2—ocular cancer	0.00334	0.00403	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.0033	0.00399	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00329	0.00398	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—HDAC1—ocular cancer	0.00327	0.00394	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00323	0.0039	CbGpPWpGaD
Capecitabine—Hypocalcaemia—Dactinomycin—ocular cancer	0.00317	0.0184	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.00312	0.00376	CbGpPWpGaD
Capecitabine—Ulcer—Dactinomycin—ocular cancer	0.00306	0.0178	CcSEcCtD
Capecitabine—DPYD—Metabolism—PSPH—ocular cancer	0.00293	0.00353	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.00284	0.00343	CbGpPWpGaD
Capecitabine—Infection—Carboplatin—ocular cancer	0.00277	0.0161	CcSEcCtD
Capecitabine—CES1—E2F transcription factor network—RB1—ocular cancer	0.00274	0.00331	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—E2F1—ocular cancer	0.00269	0.00324	CbGpPWpGaD
Capecitabine—Oesophagitis—Dactinomycin—ocular cancer	0.00265	0.0154	CcSEcCtD
Capecitabine—Mouth ulceration—Dactinomycin—ocular cancer	0.00262	0.0152	CcSEcCtD
Capecitabine—CDA—Metabolism—PSPH—ocular cancer	0.00261	0.00315	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—ocular cancer	0.00253	0.00306	CbGpPWpGaD
Capecitabine—Sepsis—Dactinomycin—ocular cancer	0.00251	0.0146	CcSEcCtD
Capecitabine—Phlebitis—Dactinomycin—ocular cancer	0.00244	0.0142	CcSEcCtD
Capecitabine—Pain—Carboplatin—ocular cancer	0.00238	0.0139	CcSEcCtD
Capecitabine—Hepatic failure—Dactinomycin—ocular cancer	0.00234	0.0136	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.00233	0.00282	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.00232	0.0028	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDK2—ocular cancer	0.00232	0.0028	CbGpPWpGaD
Capecitabine—Body temperature increased—Carboplatin—ocular cancer	0.0022	0.0128	CcSEcCtD
Capecitabine—Lethargy—Dactinomycin—ocular cancer	0.00215	0.0125	CcSEcCtD
Capecitabine—CES1—E2F transcription factor network—CDKN1B—ocular cancer	0.00214	0.00258	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PSPH—ocular cancer	0.00209	0.00252	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.00201	0.00243	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.002	0.00241	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.002	0.00241	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CDKN1A—ocular cancer	0.00197	0.00238	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00196	0.00236	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—E2F1—ocular cancer	0.00195	0.00235	CbGpPWpGaD
Capecitabine—Liver function test abnormal—Dactinomycin—ocular cancer	0.00194	0.0113	CcSEcCtD
Capecitabine—TYMS—E2F transcription factor network—RB1—ocular cancer	0.0019	0.0023	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.0019	0.0023	CbGpPWpGaD
Capecitabine—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.00189	0.011	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Dactinomycin—ocular cancer	0.00189	0.011	CcSEcCtD
Capecitabine—CES1—E2F transcription factor network—EP300—ocular cancer	0.00188	0.00227	CbGpPWpGaD
Capecitabine—Dysphagia—Dactinomycin—ocular cancer	0.00182	0.0106	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00179	0.00216	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—ocular cancer	0.00176	0.00212	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2C—ocular cancer	0.00175	0.00211	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—GNA11—ocular cancer	0.00173	0.00209	CbGpPWpGaD
Capecitabine—Pancytopenia—Dactinomycin—ocular cancer	0.00173	0.01	CcSEcCtD
Capecitabine—Neutropenia—Dactinomycin—ocular cancer	0.0017	0.00989	CcSEcCtD
Capecitabine—TYMS—G1/S Transition—CDK2—ocular cancer	0.00168	0.00203	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00166	0.002	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.00164	0.00198	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—MYC—ocular cancer	0.00164	0.00197	CbGpPWpGaD
Capecitabine—Pneumonia—Dactinomycin—ocular cancer	0.00163	0.00949	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00163	0.00197	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—GNAQ—ocular cancer	0.00161	0.00195	CbGpPWpGaD
Capecitabine—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.00161	0.00935	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—E2F4—ocular cancer	0.0016	0.00193	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.0016	0.00193	CbGpPWpGaD
Capecitabine—Stomatitis—Dactinomycin—ocular cancer	0.00158	0.00919	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00156	0.00189	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00156	0.00189	CbGpPWpGaD
Capecitabine—Agranulocytosis—Dactinomycin—ocular cancer	0.00151	0.0088	CcSEcCtD
Capecitabine—TYMS—E2F transcription factor network—CDKN1B—ocular cancer	0.00148	0.00179	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—E2F5—ocular cancer	0.00146	0.00176	CbGpPWpGaD
Capecitabine—Hepatitis—Dactinomycin—ocular cancer	0.00146	0.00847	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—HDAC1—ocular cancer	0.00145	0.00175	CbGpPWpGaD
Capecitabine—Pharyngitis—Dactinomycin—ocular cancer	0.00144	0.0084	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00144	0.00173	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYBL2—ocular cancer	0.00143	0.00172	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—E2F4—ocular cancer	0.00143	0.00172	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00142	0.00171	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00141	0.0017	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RBL1—ocular cancer	0.0014	0.00169	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—E2F2—ocular cancer	0.0014	0.00169	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—RB1—ocular cancer	0.00138	0.00167	CbGpPWpGaD
Capecitabine—Erythema multiforme—Dactinomycin—ocular cancer	0.00138	0.00801	CcSEcCtD
Capecitabine—TYMS—E2F transcription factor network—CDKN1A—ocular cancer	0.00137	0.00165	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00136	0.00164	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00136	0.00164	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00136	0.00164	CbGpPWpGaD
Capecitabine—Flushing—Dactinomycin—ocular cancer	0.00135	0.00786	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00134	0.00162	CbGpPWpGaD
Capecitabine—Chills—Dactinomycin—ocular cancer	0.00131	0.0076	CcSEcCtD
Capecitabine—TYMS—E2F transcription factor network—EP300—ocular cancer	0.0013	0.00157	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00129	0.00156	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.00129	0.00156	CbGpPWpGaD
Capecitabine—Alopecia—Dactinomycin—ocular cancer	0.00129	0.00748	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—RBL2—ocular cancer	0.00128	0.00155	CbGpPWpGaD
Capecitabine—Erythema—Dactinomycin—ocular cancer	0.00127	0.00737	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00126	0.00152	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00124	0.0015	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00123	0.00148	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—E2F3—ocular cancer	0.00121	0.00146	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RBBP4—ocular cancer	0.00121	0.00146	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00119	0.00144	CbGpPWpGaD
Capecitabine—Ill-defined disorder—Dactinomycin—ocular cancer	0.00118	0.00684	CcSEcCtD
Capecitabine—Anaemia—Dactinomycin—ocular cancer	0.00117	0.00681	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—RB1—ocular cancer	0.00116	0.00141	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDC25A—ocular cancer	0.00115	0.00139	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00114	0.00138	CbGpPWpGaD
Capecitabine—Malaise—Dactinomycin—ocular cancer	0.00114	0.00665	CcSEcCtD
Capecitabine—TYMS—E2F transcription factor network—MYC—ocular cancer	0.00113	0.00137	CbGpPWpGaD
Capecitabine—Leukopenia—Dactinomycin—ocular cancer	0.00113	0.0066	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—TFDP1—ocular cancer	0.00113	0.00136	CbGpPWpGaD
Capecitabine—Myalgia—Dactinomycin—ocular cancer	0.00108	0.00628	CcSEcCtD
Capecitabine—TYMS—G1/S Transition—CDKN1B—ocular cancer	0.00108	0.0013	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00107	0.0013	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PSPH—ocular cancer	0.00107	0.00129	CbGpPWpGaD
Capecitabine—Discomfort—Dactinomycin—ocular cancer	0.00107	0.0062	CcSEcCtD
Capecitabine—Oedema—Dactinomycin—ocular cancer	0.00103	0.00602	CcSEcCtD
Capecitabine—Infection—Dactinomycin—ocular cancer	0.00103	0.00598	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CCND3—ocular cancer	0.00102	0.00123	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00101	0.00123	CbGpPWpGaD
Capecitabine—Thrombocytopenia—Dactinomycin—ocular cancer	0.00101	0.00589	CcSEcCtD
Capecitabine—TYMS—G1/S Transition—CDKN1A—ocular cancer	0.000993	0.0012	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000986	0.00119	CbGpPWpGaD
Capecitabine—Anorexia—Dactinomycin—ocular cancer	0.000985	0.00573	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—CDK4—ocular cancer	0.000974	0.00118	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.000942	0.00548	CcSEcCtD
Capecitabine—CES1—NRF2 pathway—TGFB1—ocular cancer	0.000937	0.00113	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GNA11—ocular cancer	0.000921	0.00111	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000907	0.00109	CbGpPWpGaD
Capecitabine—Decreased appetite—Dactinomycin—ocular cancer	0.000899	0.00523	CcSEcCtD
Capecitabine—Fatigue—Dactinomycin—ocular cancer	0.000891	0.00519	CcSEcCtD
Capecitabine—Pain—Dactinomycin—ocular cancer	0.000884	0.00514	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000865	0.00104	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GNAQ—ocular cancer	0.000856	0.00103	CbGpPWpGaD
Capecitabine—Feeling abnormal—Dactinomycin—ocular cancer	0.000852	0.00496	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000852	0.00103	CbGpPWpGaD
Capecitabine—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000845	0.00492	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000837	0.00101	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—MYC—ocular cancer	0.000823	0.000994	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GNA11—ocular cancer	0.000821	0.000991	CbGpPWpGaD
Capecitabine—Body temperature increased—Dactinomycin—ocular cancer	0.000817	0.00476	CcSEcCtD
Capecitabine—Abdominal pain—Dactinomycin—ocular cancer	0.000817	0.00476	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00081	0.000978	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GNAQ—ocular cancer	0.000763	0.000922	CbGpPWpGaD
Capecitabine—Hypersensitivity—Dactinomycin—ocular cancer	0.000762	0.00443	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDK6—ocular cancer	0.000762	0.00092	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000752	0.000908	CbGpPWpGaD
Capecitabine—Asthenia—Dactinomycin—ocular cancer	0.000742	0.00432	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000732	0.000884	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000732	0.000884	CbGpPWpGaD
Capecitabine—Diarrhoea—Dactinomycin—ocular cancer	0.000707	0.00412	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000694	0.000838	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000687	0.000829	CbGpPWpGaD
Capecitabine—Vomiting—Dactinomycin—ocular cancer	0.000657	0.00382	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000657	0.000793	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GNA11—ocular cancer	0.000656	0.000792	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000655	0.000791	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—HDAC1—ocular cancer	0.000655	0.000791	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND2—ocular cancer	0.000655	0.000791	CbGpPWpGaD
Capecitabine—Rash—Dactinomycin—ocular cancer	0.000652	0.00379	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000634	0.000765	CbGpPWpGaD
Capecitabine—Nausea—Dactinomycin—ocular cancer	0.000614	0.00357	CcSEcCtD
Capecitabine—TYMP—Metabolism—GNAQ—ocular cancer	0.00061	0.000737	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000603	0.000728	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000603	0.000728	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2B—ocular cancer	0.000587	0.000709	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—EP300—ocular cancer	0.000579	0.000699	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—E2F1—ocular cancer	0.000539	0.000651	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000526	0.000635	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000524	0.000633	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDK2—ocular cancer	0.00052	0.000628	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000491	0.000593	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDK2—ocular cancer	0.000465	0.000561	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDK4—ocular cancer	0.000439	0.00053	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000432	0.000521	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—RB1—ocular cancer	0.000427	0.000516	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TP53—ocular cancer	0.000414	0.0005	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RB1—ocular cancer	0.000382	0.000461	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000364	0.00044	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GNA11—ocular cancer	0.000336	0.000405	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000333	0.000402	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MDM2—ocular cancer	0.000326	0.000393	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000317	0.000383	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GNAQ—ocular cancer	0.000312	0.000377	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—EP300—ocular cancer	0.000308	0.000372	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PSPH—ocular cancer	0.000308	0.000371	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000307	0.000371	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN1B—ocular cancer	0.000297	0.000359	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—EP300—ocular cancer	0.000292	0.000353	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND1—ocular cancer	0.000284	0.000342	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN1A—ocular cancer	0.000274	0.000331	CbGpPWpGaD
Capecitabine—CDA—Metabolism—EP300—ocular cancer	0.000274	0.000331	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—EP300—ocular cancer	0.000261	0.000315	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—ocular cancer	0.000254	0.000307	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—ocular cancer	0.000228	0.000275	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—EP300—ocular cancer	0.000219	0.000265	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—ocular cancer	0.000187	0.000226	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKT1—ocular cancer	0.000186	0.000225	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—ocular cancer	0.000166	0.0002	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—ocular cancer	0.000133	0.00016	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—EP300—ocular cancer	0.000112	0.000135	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GNA11—ocular cancer	9.68e-05	0.000117	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GNAQ—ocular cancer	9e-05	0.000109	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.26e-05	8.77e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—ocular cancer	6.78e-05	8.18e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—EP300—ocular cancer	3.23e-05	3.9e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—ocular cancer	1.95e-05	2.36e-05	CbGpPWpGaD
